Fig. 2
From: Loss of H3K27 methylation identifies poor outcomes in adult-onset acute leukemia
Overall survival (OS) in a AML patients (n = 241) stratified in three equally divided patient groups based on H3K27me3, b AML patients (n = 241) stratified in two groups, c younger AML patients (< 65 years, n = 127) and d AML patients older than 65 years (n = 114) according to H3K27me3 low (blue) and high (orange) status